TLDR
- First-quarter revenue reached $5.43 billion, surpassing analyst projections of $4.57 billion by 18.6%
- Earnings per share on an adjusted basis hit $1.32, outperforming the $1.25 consensus by 5.9%
- Strategic price increases fueled revenue expansion despite declining shipment volumes
- Market share for Marlboro cigarettes declined by 1.4 percentage points in the overall category
- Company maintained its full-year adjusted earnings guidance with a $5.64 midpoint target
Altria delivered impressive first-quarter results that exceeded analyst forecasts across key metrics. The Richmond-based tobacco manufacturer generated quarterly sales of $5.43 billion, representing a 20.1% year-over-year increase and substantially above the $4.57 billion Wall Street consensus.
On a per-share basis, adjusted earnings registered $1.32, comfortably exceeding analyst estimates of $1.25 by 5.9%. The figure represents a 7.3% year-over-year improvement in adjusted diluted earnings per share.
The quarter ending March 31 saw net income climb to $2.18 billion, translating to $1.30 per diluted share. This represents significant growth from the prior-year period’s $1.08 billion, or 63 cents per share.
Operating income on an adjusted basis totaled $3.03 billion, exceeding expectations of $2.83 billion while delivering a 55.9% operating margin. This marks a substantial improvement from the 39.6% margin recorded in last year’s first quarter.
Strategic Pricing Drives Performance
The smokeable products division proved to be the quarter’s standout performer. Revenue expansion came through strategic price increases that more than compensated for reduced shipment volumes and elevated promotional spending.
Similarly, the oral tobacco business recorded revenue gains powered by pricing initiatives, even as unit volumes trended downward. This strategy reflects Altria‘s longstanding approach of prioritizing margin protection through premium pricing while accepting volume declines.
The company’s premier Marlboro brand experienced a 1.4 percentage point decline in overall cigarette market share throughout the quarter. Despite this, Altria noted that Marlboro actually increased its position within the premium cigarette segment.
The on! nicotine pouch product line saw market share slip by less than 1 percentage point. This emerging category represents a strategic priority for the company’s growth initiatives.
Full-Year Outlook Unchanged Despite Headwinds
Management reaffirmed the company’s full-year adjusted earnings per share projection with a midpoint of $5.64. The maintained guidance now incorporates assumptions for weaker-than-anticipated growth in the electronic vapor industry.
Additionally, the company acknowledged heightened macroeconomic pressures affecting adult consumers as a factor embedded in the current forecast. Despite these challenges, Altria opted to maintain its existing outlook.
Chief Executive Billy Gifford characterized the quarter as “a strong start to the year,” highlighting the 7.3% adjusted earnings growth as validation that the business is executing according to plan.
With a market capitalization hovering around $114 billion, Altria ranks among the largest companies in the consumer staples sector.
Trailing twelve-month revenue stands at $21.05 billion — essentially unchanged from three years prior, illustrating persistent demand challenges that pricing strategies have worked to offset.
Wall Street analysts currently project a 3.5% revenue contraction over the coming 12 months. This forecast acknowledges continued volume headwinds affecting the broader tobacco sector.
While the company exceeded both revenue and profit expectations, declining volumes remain a structural headwind. Price optimization has successfully counterbalanced this trend thus far, though the sustainability of aggressive pricing has natural limits.
The first quarter’s adjusted operating income of $3.03 billion surpassed analyst projections by 7.2%, demonstrating Altria’s continued ability to extract profitability even amid challenging demand conditions.
